BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//InBio - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://inbio.com
X-WR-CALDESC:Events for InBio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260227
DTEND;VALUE=DATE:20260303
DTSTAMP:20260405T085426
CREATED:20260220T190128Z
LAST-MODIFIED:20260220T190128Z
UID:3197-1772150400-1772495999@inbio.com
SUMMARY:InBio Attending AAAAI 2026
DESCRIPTION:InBio Attending AAAAI in Philadelphia\, February 27th-March 2nd 2026\nInBio is looking forward to this year’s American Academy of Allergy\, Asthma & Immunology (AAAAI) Annual Meeting in Philadelphia! With its cobblestone streets\, historic neighborhoods\, and landmarks like Independence Hall and the Liberty Bell\, Philadelphia blends rich American history with a vibrant modern culture\, world-class museums\, and an outstanding food scene. \nInBio is delighted to announce that Martin Chapman\, PhD\, FAAAAI\, President & CEO of InBio\, is the recipient of the Jordan N. Fink Memorial Lectureship. This award will be presented prior to Martin’s plenary lecture on “Developing Precision Diagnostics and Therapeutics in Atopic Diseases”\, this Saturday\, Feb 28th at 8:15am EST in Level 2\, Hall E. \nCongratulations to Martin on this outstanding achievement\, which is thoroughly deserved and represents peer recognition of Martin’s research over the past 40+ years at the highest level. A globally recognized leader in allergen science and translational innovation\, Martin has helped shape the field for decades. His plenary lecture is not to be missed! \nInBio scientists will be presenting several abstracts at AAAAI 2026. Most prominently\, InBio and collaborators will present the allergenic structure of cat allergen\, Fel d 1\, as defined using human IgE monoclonal antibodies. We will be sharing the formulation of a synthetic ‘serum’ comprising of human IgE monoclonal antibodies to peanut allergens\, together with recent data on the use of Apollo for detection of airborne microbes. \nFind a full list of InBio’s presentations and posters here. InBio will be at booth #608\, hope to see you there!
URL:https://inbio.com/event/inbio-attending-aaaai-2026/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260218T110000
DTEND;TZID=America/New_York:20260218T120000
DTSTAMP:20260405T085426
CREATED:20260128T193354Z
LAST-MODIFIED:20260220T185611Z
UID:3029-1771412400-1771416000@inbio.com
SUMMARY:InBio Webinar: Latest Innovations in Basophil Activation Testing for Food Allergy Investigation
DESCRIPTION:BAT Webinar – ON DEMAND \nLatest Innovations in Basophil Activation Testing for Food Allergy Investigation \n \nWATCH ON DEMAND HERE \nInBio is teaming up with Beckman Coulter to bring you a webinar on Wednesday\, February 18th that will explore how next-generation basophil activation testing can simplify workflows\, improve reproducibility and overcome common bottlenecks in food allergy research. \nThe webinar will discuss how Beckman Coulter’s streamlined\, robust\, and easy-to-use Basophil Activation Test (BAT)—leveraging innovative dry technology and InBio’s high quality food protein standards—is designed to overcome traditional limitations in allergy testing. \n  \nWhat’s on the Agenda \nExplore technical advances in BAT for simplified implementation \nUnderstand how food protein standards are manufactured with defined allergen composition \nLearn validation processes that ensure reproducibility and reliability \nDiscuss how molecular approaches can improve allergy platforms \n  \nThe webinar is available on-demandm\, watch here. \nSpeakers\n \n  \nSabina Wuenschmann\, PhD\, is Vice President of Allergen Manufacturing and R&D at InBio\, where she has led scientific innovation and product development for over 15 years. Her career spans virology research\, allergen molecular research\, and proteomics with a strong focus on translating science into high-quality commercial solutions for global diagnostic and research markets. Research made real! \n  \nJean-Marc Busnel\, PhD is head of the Translational Research Team of Beckman Coulter Life Sciences and co-author of more than 55 peer-reviewed articles in the fields of bioanalytical chemistry\, metabolomics\, proteomics and whole blood based functional flow cytometry assays. Dr. Busnel works on further leveraging the capabilities of Flow Cytometry for patient stratification in various pathological areas such as allergy\, autoimmunity\, infectious diseases and oncology. \n  \nFind full bios and more details on the webinar here.  \n  \nCan’t attend live? Register here and we will send you a recording after the webinar to all registrants.  Hope to see you there!
URL:https://inbio.com/event/inbio-webinar-latest-innovations-in-basophil-activation-testing-for-food-allergy-investigation/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251111
DTEND;VALUE=DATE:20251114
DTSTAMP:20260405T085426
CREATED:20251029T201129Z
LAST-MODIFIED:20251029T202021Z
UID:2931-1762819200-1763078399@inbio.com
SUMMARY:InBio at ISSA 2025
DESCRIPTION:InBio will be at ISSA 2025 in Las Vegas\, November 11th-13th. \nPlease find details of the conference here. Come by to learn more about validating your allergen removal claim! \nContact Meagan Cook (mcook@inbio.com) if you’d like to setup a meeting. \n\n  \n 
URL:https://inbio.com/event/inbio-at-issa-2025/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250922
DTEND;VALUE=DATE:20250925
DTSTAMP:20260405T085426
CREATED:20250703T143330Z
LAST-MODIFIED:20250911T090051Z
UID:2802-1758499200-1758758399@inbio.com
SUMMARY:InBio Attending Food Allergy Forum in 2025
DESCRIPTION:InBio is excited to attend and exhibit at the Food Allergy Forum September 22nd through September 24th in Amsterdam\, which will focus on food allergen risk assessment and risk management to improve the protection of the food allergic consumer; allergenicity assessment to prevent allergies to new food products; and maintenance and optimisation of immune health to improve prevention and therapy. \nPlease find details of the conference here. Come by to learn more on InBio’s Molecular Approach to Food Allergy! \nContact Ross Yarham (Ryarham@inbio.com) if you’d like to setup a meeting. \n \n  \n 
URL:https://inbio.com/event/inbio-attending-faf-in-2025/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250729
DTEND;VALUE=DATE:20250801
DTSTAMP:20260405T085426
CREATED:20250528T195754Z
LAST-MODIFIED:20250528T201402Z
UID:2725-1753747200-1754006399@inbio.com
SUMMARY:InBio at ADLM 2025
DESCRIPTION:InBio is excited to be exhibiting at ADLM 2025 in Chicago. With InBio’s molecular approach to allergy\, we are uniquely suited to aid in your molecular allergy diagnostics\, standardization and immunotherapy drug development efforts. \nCome by booth #1658 or email Beattie Sturgill to discuss how InBio can assist in your diagnostic needs. Hope to see you there!
URL:https://inbio.com/event/inbio-at-adlm-2025/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250613
DTEND;VALUE=DATE:20250617
DTSTAMP:20260405T085426
CREATED:20250514T100921Z
LAST-MODIFIED:20250528T192906Z
UID:2702-1749772800-1750118399@inbio.com
SUMMARY:InBio Attending EAACI in 2025
DESCRIPTION:InBio is excited to attend the EAACI annual Congress June 13th through June 16th in Glasgow! InBio scientists will be presenting data on the optimal food allergen extraction methods from challenging matrices; our novel air sampler for airborne microbes; how baking effects the measurement of food allergens\, and more! \nInBio will be at booth A50\, drop by and let’s discuss how we can work together! \nContact Ross Yarham (Ryarham@inbio.com) if you’d like to setup a meeting. \n \n  \n 
URL:https://inbio.com/event/inbio-attending-eaaci-2025/
LOCATION:SEC Glasgow\, SEC\, Exhibition Way\, Glasgow\, United Kingdom
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250228
DTEND;VALUE=DATE:20250303
DTSTAMP:20260405T085426
CREATED:20241224T141618Z
LAST-MODIFIED:20250220T152831Z
UID:2497-1740700800-1740959999@inbio.com
SUMMARY:InBio Attending AAAAI 2025
DESCRIPTION:InBio Attending AAAAI in San Diego\, February 28th-March 2nd 2025\nInBio is excited to attend the AAAAI annual conference February 28th through March 2nd in San Diego.\, where InBio scientists will be presenting data on the variability of peanut containing products used in oral immunotherapies (OIT)\, deficiencies of allergen levels in a commonly used protocol for OIT\, hypoallergenic Der p 2 mutants\, and more. \nInBio will be at booth #1747\, hope to see you there!
URL:https://inbio.com/event/inbio-attending-aaaai-2025/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Rome:20241008T090000
DTEND;TZID=Europe/Rome:20241008T100000
DTSTAMP:20260405T085426
CREATED:20240930T164959Z
LAST-MODIFIED:20241001T195552Z
UID:2325-1728378000-1728381600@inbio.com
SUMMARY:InBio participating in World Standards Day
DESCRIPTION:InBio is excited to be participating in Merck’s World Standards Day! The annual celebration is to help raise awareness of the role that standards play in addressing global priorities. \nInBio will be presenting a webinar on Food Allergen Standards: A Multi-faceted Approach for Molecular Standardization on October 8th at 9am CEST. You can find a link to register for the webinar here. Drs. Martin Chapman and Sabina Wuenschmann have exciting updates\, including advances in analytical techniques through case studies and the release of InBio’s newest product\, a molecular peanut composite. \nHope you can attend! A recording of the webinar will be provided to registrants.
URL:https://inbio.com/event/inbio-participating-in-world-standards-day/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240730
DTEND;VALUE=DATE:20240802
DTSTAMP:20260405T085426
CREATED:20240716T154906Z
LAST-MODIFIED:20240716T154906Z
UID:2110-1722297600-1722556799@inbio.com
SUMMARY:InBio at ADLM 2024
DESCRIPTION:InBio at ADLM 2024 in Chicago\, July 30th through August 1st\nInBio is excited to be presenting and exhibiting at ADLM (Association for Diagnostics and Laboratory Medicine\, formerly AACC) 2024 in Chicago. Stephanie Filep\, Director of Laboratory Services\, will be presenting on human IgE monoclonal antibodies as unique tools for allergy diagnostics. With InBio’s molecular approach to allergy\, we are uniquely suited to aid in your molecular allergy diagnostics\, standardization and immunotherapy drug development efforts. \nCome by booth #4557 or email Beattie Sturgill to discuss how InBio can assist in your diagnostic needs. Hope to see you there!
URL:https://inbio.com/event/inbio-attending-adlm-2024/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240707
DTEND;VALUE=DATE:20240712
DTSTAMP:20260405T085426
CREATED:20240514T194254Z
LAST-MODIFIED:20240703T102325Z
UID:2021-1720310400-1720742399@inbio.com
SUMMARY:InBio Attending Indoor Air 2024
DESCRIPTION:InBio Attending Indoor Air in Honolulu\, July 7th-11th 2024\nInBio\, the world leader in environmental allergen detection\, is excited to be attending the Indoor Air 2024 Conference in Honolulu\, Hawaii! The Indoor Air 2024 Conference provides a multidisciplinary and holistic view on indoor air science. Stephanie Filep\, Director of Laboratory Services\, will be presenting on the environmental assessment of airborne allergens using Apollo\, a novel ambient air sampling device that InBio has just released. \nCome by our booth or email Beattie Sturgill to see Apollo in action or to discuss how InBio can assist in your allergen analysis needs. Hope to see you there!
URL:https://inbio.com/event/inbio-attending-indoor-air-2024/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240620
DTEND;VALUE=DATE:20240622
DTSTAMP:20260405T085426
CREATED:20240620T080828Z
LAST-MODIFIED:20240620T080828Z
UID:2091-1718841600-1719014399@inbio.com
SUMMARY:InBio Attending the Occupational Health Annual Scientific Meeting 2024
DESCRIPTION:InBio Exhibiting at the Occupational Health Annual Scientific Meeting\, June 20th-21th 2024\nInBio\, the world leader in environmental allergen detection\, is excited to be attending the Occupational Health Annual Scientific Meeting in Belfast\, Ireland\, held at the spectacular Titanic exhibition. The meeting provides a multidisciplinary view on occupational health including important considerations around respiratory health in the workplace. InBio will be displaying our full range of environmental testing services and sampling options\, including our new Apollo ambient air sampling device. \nCome by our booth or email Ross Yarham to see Apollo in action or to discuss how InBio can assist in your allergen analysis needs. Hope to see you there!
URL:https://inbio.com/event/inbio-attending-occupational-health-2024/
LOCATION:Titanic Belfast
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240520
DTEND;VALUE=DATE:20240523
DTSTAMP:20260405T085426
CREATED:20240507T143720Z
LAST-MODIFIED:20240507T143720Z
UID:2012-1716163200-1716422399@inbio.com
SUMMARY:InBio Attending AIHA Connect 2024 in Columbus\, Ohio.
DESCRIPTION:InBio Attending AIHA Connect 2024 in Columbus\, Ohio\, 20-22 May 2024. \nInBio\, the world leader in environmental allergen detection\, is excited to at AIHA Connect 2024 in Columbus\, Ohio May 20th-22nd. Stephanie Filep\, Director of Lab Services\, will be presenting on the environmental assessment of airborne allergens using Apollo\, a novel ambient air sampling device that InBio has just released. Stephanie will be presenting on Wednesday\, May 22nd from 10:30AM-11:30AM ET. \nCome by Booth #632 or email Beattie Sturgill to see an Apollo in action or to discuss how InBio can assist in your allergen analysis needs. Hope to see you there!
URL:https://inbio.com/event/inbio-attending-aiha-2024/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240514
DTEND;VALUE=DATE:20240518
DTSTAMP:20260405T085426
CREATED:20240507T135359Z
LAST-MODIFIED:20240507T135832Z
UID:2006-1715644800-1715990399@inbio.com
SUMMARY:InBio Attending InterClean 2024 in Amsterdam.
DESCRIPTION:InBio Attending InterClean 2024 in Amsterdam\, 14-17 May 2024. \nInBio is excited to attend and exhibit at InterClean 2024! This will be the first time InBio has exhibited at InterClean\, sharing unique product testing capabilities including ‘real-world’ allergen testing dust\, MARIA immunoassay for multiple allergen measurements\, robust testing methods\, and state-of-the-art environmental testing chambers. \nInterclean is the world’s leading platform for professionals in the world of cleaning and hygiene. As an exhibitor we can extend a free-invitation to our colleagues & customers so please get in touch if you’d like to be our guest! \nInBio will be at stand 10.508 in the washroom area. Check out our exhibitor page here. \nHope to see you there!
URL:https://inbio.com/event/inbio-attending-interclean-2024/
LOCATION:RAI Amsterdam\, Europaplein 24\, Amsterdam\, 1078 GZ\, Netherlands
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240223
DTEND;VALUE=DATE:20240228
DTSTAMP:20260405T085426
CREATED:20240214T190936Z
LAST-MODIFIED:20240214T190936Z
UID:1921-1708646400-1709078399@inbio.com
SUMMARY:InBio Attending AAAAI 2024
DESCRIPTION:InBio Attending AAAAI in Washington D.C.\, 23-26 February 2024\nInBio is excited to attend the AAAAI annual conference February 23rd through the 26th in Washington D.C.\, where InBio scientists will be presenting data on human IgE monoclonal antibodies to alpha-gal and the epitope repertoire of Der p 2. Our collaborator\, Dr. Kriti Khatri will present the first ever structure of a human IgE mAb epitope on dog allergen\, Can f 1. Other posters focus on the development of food reference materials and on Alpha/Gamma-Gliadins as targets in wheat allergy. \nPlease find details of the InBio’s presence at the conference here. InBio will be at booth #755\, hope to see you there!
URL:https://inbio.com/event/inbio-attending-aaaai-2024/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231121
DTEND;VALUE=DATE:20231124
DTSTAMP:20260405T085426
CREATED:20231122T124817Z
LAST-MODIFIED:20231122T124817Z
UID:1860-1700524800-1700783999@inbio.com
SUMMARY:InBio Attending LASA 2023
DESCRIPTION:InBio is excited to attend and exhibit at the Laboratory Animal Science Association 2023 conference\, 21st-23rd November in Cambridge\, celebrating their 60th anniversary. LASA is the UK society for scientists and laboratory animal professionals with an interest in animal research\, 3Rs\, care and welfare\, education\, training and ethics\, and policy and regulation. \nPlease find details of the conference here. Come by to learn more on InBio’s Lab Animal Allergen testing services and our unique sampling solutions\, including our new Apollo Air Sampler!
URL:https://inbio.com/event/inbio-attending-lasa-2023/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231102T100000
DTEND;TZID=America/New_York:20231102T110000
DTSTAMP:20260405T085426
CREATED:20231011T143852Z
LAST-MODIFIED:20231011T153138Z
UID:1814-1698919200-1698922800@inbio.com
SUMMARY:InBio Webinar: Food Allergy Diagnostics- Reducing Uncertainty
DESCRIPTION:Food Allergy Diagnostics- Reducing Uncertainty 02 Nov 2023\nRegister here \nRecent reports of false negative reactions upon skin testing with diagnostic food allergens raise serious concerns for food allergic patients and their health care providers. In December 2022\, ALK-Abelló\, the world’s largest allergen manufacturer\, voluntarily recalled 4 lots of peanut extract that gave false negative reactions on skin testing and were associated with adverse events\, including life-threatening anaphylaxis. In March\, the U.S. Food and Drug Administration introduced safety labeling changes for all diagnostic food allergenic extracts including a Warning of anaphylaxis following false negative skin tests. \nThe FDA Warning proved to be profound. In September\, ALK-Abelló voluntarily withdrew one lot of diagnostic pecan extract following false negative skin test results associated with adverse events including one case of life-threatening anaphylaxis. \nCollaborative studies with Drs. Cosby Stone and Scott Smith (Vanderbilt University) and Jonathan Hemler (University of Virginia) showed significant differences between recall and non-recall lots of the diagnostic peanut extracts. The recall lots contained negligible amounts of major peanut allergens by either InBio murine mAb ELISA or using human IgE mAb ELISA. These studies underscore the value of measuring specific allergens for quality control and standardization purposes. \nThere is an urgent need for standardization of food allergen extracts. Over the past 25 years\, InBio has developed a multi-faceted approach to allergen standardization which includes biochemical methods\, immunoassays\, mass spectrometry and human IgE monoclonal antibodies. \nJoin InBio scientists to discuss the food allergen recalls\, as well as recent advances in molecular diagnostics and standardization on Thursday\, November 2nd at 10am EDT. Register here. \nSpeakers\n \nLearning Objectives: \n\nUnderstand the significance behind the food extract recalls.\nUnderstand the multi-faceted approach in allergen standardization.\nDiscuss the latest research on InBio’s exclusive product\, human IgE monoclonal antibodies.\n\nWhen: Thursday\, November 2nd\, 2023 10am EDT. \nWe hope that you can join us and attend the webinar. There will be plenty of opportunity for discussion in the Q&A. Please contact Beattie Sturgill with any questions or comments. Register here.
URL:https://inbio.com/event/inbio-webinar-food-allergy-diagnostics/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230927
DTEND;VALUE=DATE:20230929
DTSTAMP:20260405T085426
CREATED:20230830T185251Z
LAST-MODIFIED:20230830T185251Z
UID:1522-1695772800-1695945599@inbio.com
SUMMARY:InBio Attending Cleaning Products US 2023
DESCRIPTION:InBio Attending Cleaning Products US in Washington D.C.\, 27-28 September 2023\nInBio is excited to attend and sponsor the Cleaning Products US annual conference September 27th through the 28th in Washington D.C.\, which is the leading conference in the US dedicated to providing focused insights on new trends and innovations in the cleaning product industry. \nPlease find details of the conference here. Hope to see you there!
URL:https://inbio.com/event/inbio-attending-cleaning-products-us-2023/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230927
DTEND;VALUE=DATE:20230930
DTSTAMP:20260405T085426
CREATED:20230110T172918Z
LAST-MODIFIED:20230809T091708Z
UID:888-1695772800-1696031999@inbio.com
SUMMARY:InBio Attending Food Allergy Forum 2023
DESCRIPTION:InBio is excited to attend and sponsor the annual Food Allergy Forum September 27th through September 29th in Amsterdam\, which provides a unique platform for the food industry\, science\, and regulatory authorities to exchange information and experiences of the various aspects of food allergy. \nPlease find details of the conference here. Come by to learn more on InBio’s Molecular Approach to Food Allergy!
URL:https://inbio.com/event/inbio-attending-food-allergy-forum-2023/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230906
DTEND;VALUE=DATE:20230910
DTSTAMP:20260405T085426
CREATED:20230807T155604Z
LAST-MODIFIED:20230809T091638Z
UID:1493-1693958400-1694303999@inbio.com
SUMMARY:InBio Attending the 16th In­ter­na­tion­al Paul-Ehrlich-Sem­i­nar (IPES) 2023
DESCRIPTION:InBio is excited to be attending the 16th International Paul-Ehrlich-Seminar (IPES) 2023 September 6th through September 9th. We are looking forward to reconnecting with our peers\, customers and other experts in the field to discuss the state-of-the-art topics of regulation and science of commercial allergenic products. Details of the event here. \n\nCome and speak to us about our participation in the European Directorate for Quality of Medicines and HealthCare (EDQM) Biological Standardization Program BSP090 to develop a Bet v 1 ELISA 2.0 EP assay as an alternative to the method described in the General Chapter 2.7.36 of the European Pharmacopoeia (Ph.Eur.) \n\n\nInBio has also developed a Phl p 5 ELISA 2.0 method which has been successfully evaluated by the EDQM in a multi-centre ring trial as a suitable method for measuring Phl p 51. \nLearn more on both of these methods here.
URL:https://inbio.com/event/inbio-attending-ipes2023/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230609
DTEND;VALUE=DATE:20230613
DTSTAMP:20260405T085426
CREATED:20230426T194320Z
LAST-MODIFIED:20230517T204045Z
UID:1261-1686268800-1686614399@inbio.com
SUMMARY:InBio Attending EAACI 2023 Congress
DESCRIPTION:InBio Attending EAACI 2023 Congress in Hamburg\, 9-11 June\nInBio is excited to be attending the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2023\, June 9th through 11th. The EAACI Congress is always one of the highlights of the year. \nYou will find us in Hall H\, Stand I60 \nCome visit us to discuss all things allergy and take a look at the Apollo\, InBio’s new air sampling device!
URL:https://inbio.com/event/inbio-attending-eaaci-2023-congress/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230531T100000
DTEND;TZID=America/New_York:20230531T110000
DTSTAMP:20260405T085426
CREATED:20230512T171524Z
LAST-MODIFIED:20230512T171605Z
UID:1361-1685527200-1685530800@inbio.com
SUMMARY:InBio Webinar- Molecular Allergy Diagnostics: Innovative Products and Resources
DESCRIPTION:InBio Webinar- Molecular Allergy Diagnostics: Innovative Products and Resources 31 May 2023\nInBio has served the allergen diagnostic industry for over 10 years. Using our proven expertise in proteomics\, InBio has designed and created a comprehensive portfolio of allergen components for diagnostic use\, including food\, dust mite\, animal\, mold\, pollen\, cockroach\, venom and other allergens. \nIn addition\, InBio has a unique portfolio of Human IgE Monoclonal Antibodies (hIgE mAb) to a diverse panel of clinically important allergens. The hIgE mAb are derived from patients with a clinical history of allergic disease and are poised to make a significant impact on research and diagnostic applications. \nJoin InBio scientists\, together with our guest speaker Dr. Lorenz Aglas\, to discuss these molecular allergy diagnostic tools and more in an interactive webinar on Wednesday\, May 31st   at 10am EDT.  Dr. Aglas will present his recent work using hIgE mAb to initiate mediator release from huRBL cells. Register here.
URL:https://inbio.com/event/inbio-webinar-molecular-allergy-diagnostics-innovative-products-and-resources/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230419
DTEND;VALUE=DATE:20230421
DTSTAMP:20260405T085426
CREATED:20230110T172443Z
LAST-MODIFIED:20230113T145925Z
UID:886-1681862400-1682035199@inbio.com
SUMMARY:InBio Attending Cleaning Products Europe 2023
DESCRIPTION:InBio Attending Cleaning Products Europe in Amsterdam\, 19-20 April 2023\nInBio is excited to attend and sponsor the Cleaning Products Europe annual conference April 19th through April 20th in Amsterdam\, which is the leading conference in Europe dedicated to providing focused insights on new trends and innovations in the cleaning product industry. \nPlease find details of the conference here. Hope to see you there!
URL:https://inbio.com/event/cleaningproductseurope2023/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230418T100000
DTEND;TZID=America/New_York:20230418T110000
DTSTAMP:20260405T085426
CREATED:20230330T143414Z
LAST-MODIFIED:20230330T143516Z
UID:1227-1681812000-1681815600@inbio.com
SUMMARY:InBio Webinar- Cleaning and Consumer Product Testing Capabilities
DESCRIPTION:InBio Webinar- Cleaning and Consumer Product Testing Capabilities 18 April 2023\nInBio has essential tools and unmatched allergen testing expertise to help cleaning and consumer product companies validate allergen removal claims. \nJoin InBio scientists to discuss details of these products and technologies on our latest webinar on Tuesday\, April 18th at 10am EDT. \nDetails of the webinar and registration (required) below\, while recordings of our other webinars can be found here.
URL:https://inbio.com/event/inbio-webinar-cleaning-and-consumer-product-testing-capabilities/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230318
DTEND;VALUE=DATE:20230323
DTSTAMP:20260405T085426
CREATED:20230207T183250Z
LAST-MODIFIED:20230315T182307Z
UID:931-1679097600-1679529599@inbio.com
SUMMARY:InBio Attending Pittcon 2023
DESCRIPTION:Dr. Martin Chapman will be speaking at Pittcon 2023 on MARIA® for Foods use in simultaneous detection and quantification of major allergens in foods. The session will be held Tuesday\, 21Mar2023 from 1:30pm-4:45pm EST in Room 120C. \n \nPlease find details of the session . Come by to learn more on InBio’s Molecular Approach to Food Allergy!
URL:https://inbio.com/event/inbio-attending-pittcon-2023/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230224
DTEND;VALUE=DATE:20230228
DTSTAMP:20260405T085426
CREATED:20230221T203233Z
LAST-MODIFIED:20230221T203426Z
UID:1109-1677196800-1677542399@inbio.com
SUMMARY:InBio Presenting at AAAAI Annual Meeting 2023
DESCRIPTION:InBio Presenting at AAAAI 2023\nInBio scientists have four posters (two late breaking) and one oral abstract at AAAAI 2023\, covering such diverse topics as T cell immune responses to Der p 2\, human IgE monoclonal antibodies\, effects of german cockroach immunotherapy\, and the genetic diversity of cat allergen\, Fel d 1. \nPlease find details of InBio’s presentations at the AAAAI meeting below. \nFriday\, February 24th\, 2023 \nLATE BREAKING ABSTRACT: The Effect of Subcutaneous German Cockroach Immunotherapy (SCIT) on Nasal Allergen Challenge (NAC) and Cockroach-specific Antibody Responses Among Urban Children and Adolescents\nLocation: Convention Center\, Lobby Level\, Hall 2\, Poster L10\nDate/Time: Friday\, February 24th from 3:15-4:15 PM \n  \nLATE BREAKING ABSTRACT: Down-Modulation of Cockroach (CR) Allergen-specific Th2 Cell Responses Following Subcutaneous German Cockroach Allergen Immunotherapy (SCIT)\nLocation: Convention Center\, Lobby Level\, Hall 2\, Poster L14\nDate/Time: Friday\, February 24th from 3:15-4:15 PM \nPoster presentation: Epitope Structural Analysis of Dust Mite Allergen Der p 2 with Human IgE Monoclonal Antibodies\nLocation: Convention Center\, Lobby Level\, Hall 2\, Poster 168\nDate/Time: Friday\, February 24th from 3:15-4:15 PM \nPoster Presentation: Genetic diversity of cat allergen\, Fel d 1\nLocation: Convention Center\, Lobby Level\, Hall 2\, Poster 169\nDate/Time: Friday\, February 24th from 3:15-4:15 PM \nSaturday\, February 25th\, 2023 \nOral Abstract: Use of a Novel High-Dimensional Single-Cell Analytical Method for Defining T-cell Skewing Induced by a Molecular Variant of Der p 2\nDate/Time: Saturday\, February 25th from 2:05-2:15 PM \n 
URL:https://inbio.com/event/inbio-presenting-at-aaaai-annual-meeting-2023/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220701
DTEND;VALUE=DATE:20220704
DTSTAMP:20260405T085426
CREATED:20221108T151512Z
LAST-MODIFIED:20221108T151922Z
UID:537-1656633600-1656892799@inbio.com
SUMMARY:InBio Attending EAACI 2022 Hybrid Congress
DESCRIPTION:InBio Attending EAACI 2022 in Prague\, 1-3 July\nInBio is excited to be physically attending the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2022\, July 1st through July 3rd. The EAACI Congress is always one of the highlights of the year. \nInBio will have two presentations and four virtual posters\, covering such diverse topics as T cell immune responses to SARS-CoV-2 variants\, the “Apollo” novel air sampler\, and major egg allergens in baked foods. InBio will also highlight the use of human IgE monoclonal antibodies (hIgE mAb) to target alpha-gal and major peanut allergens; and to locate a key determinant of in vivo anaphylaxis severity on mite allergen Der p 2. \nPlease find details of all InBio’s presentations at the EAACI Congress below. InBio will be at Booth C14 with exciting announcements and a new look. Hope to see you there! \nInBio Oral Presentation and Posters
URL:https://inbio.com/event/inbio-attending-eaaci-2022-hybrid-congress/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220425
DTEND;VALUE=DATE:20220428
DTSTAMP:20260405T085426
CREATED:20221108T151329Z
LAST-MODIFIED:20221108T151329Z
UID:536-1650844800-1651103999@inbio.com
SUMMARY:InBio Attending WAO-BSACI 2022
DESCRIPTION:InBio Attending WAO-BSACI 2022\nInBio is looking forward to attending its second big conference of the year\, the World Allergy Organization (WAO) and British Society for Allergy & Clinical Immunology (BSACI) joint conference\, in the spectacular city of Edinburgh. The last time the WAO held an event in the UK was back in 1982! We are excited to meet and learn from experts around the world. \nYou will find us at stand C6\, near the speaker’s corner\, with a whole new look. Come by tto discuss how we can help you advance products and diagnostic systems\, seize business opportunities\, and overcome real-world challenges. Hope to see you there!
URL:https://inbio.com/event/inbio-attending-wao-bsaci-2022/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220226
DTEND;VALUE=DATE:20220301
DTSTAMP:20260405T085426
CREATED:20221108T151132Z
LAST-MODIFIED:20221108T151350Z
UID:535-1645833600-1646092799@inbio.com
SUMMARY:InBio Attending AAAAI Annual Meeting 2022
DESCRIPTION:InBio Attending 2022 AAAAI \nInBio is excited to kick-off the year by attending our first big conference\, the American Academy of Allergy\, Asthma and Immunology Annual Meeting\, starting February 26th. The AAAAI Annual Meeting is always one of the highlights of the year. \nInBio will be presenting five oral abstracts and posters\, covering such diverse topics as T cell immune responses to SARS-CoV-2 vaccines\, human IgE monoclonal antibodies\, allergen levels in baked foods\, cannabis allergen\, and CRISPR for cats. \nIn other news\, InBio is delighted to announce that Dr. Anna Pomés\, Director of Research\, is the recipient of the Harold S. Nelson MD\, FAAAI Lectureship: Investing Together in Our Future. This award will be presented prior to Anna’s lecture on “Human Monoclonal IgE Antibodies to Allergens” at the National Institute of Environmental Health Sciences AAAAI Symposium 2522 on Saturday\, Feb 26th at 12:30pm MST. Congratulations to Anna on this outstanding achievement\, which is thoroughly deserved and represents peer recognition of Anna’s NIH funded research over the past 15 years. \nPlease find details of InBio’s presence at the AAAAI meeting below. InBio will be at Booth 1018 as well as on the virtual platform with exciting announcements and a new look. Hope to see you there! \nIndoor Biotechnologies scientists will be presenting five oral presentations and posters in person and virtually\, including an AAAAI Foundation and Harold S. Nelson\, MD FAAAAI Lectureship by Dr. Anna Pomés\, “Human Monoclonal IgE Antibodies to Allergens.” Find details on InBio’s 2022 AAAAI content below. \nSaturday\, February 26th\, 2022\nAAAAI Foundation and Harold S. Nelson\, MD FAAAAI Lectureship: Investing Together in Our Future (3rd year)- Human Monoclonal IgE Antibodies to Allergens\nLecturer: Anna Pomés\, PhD FAAAAI\nSession: 2522 National Institute of Environmental Health Sciences (NIEHS): Molecular Characterization of Allergens and Specific IgE Antibodies\nLocation: Convention Center\, North Building\, 100 Level\, Room 120D\nDate/Time: Saturday\, February 26th at 12:55 PM \nAbstract Title: Interleukin-2: An Accurate Biomarker for Rapid Testing of SARS-CoV-2 Vaccine-induced T cell Immune Responses in Whole Blood\nPresenter: Maria Oliver\, PhD\nSession: Caring for Patients with Immunodeficiency Disorders During the COVID-19 Pandemic\nLocation: Convention Center\, West Building\, 300 Level\, Room 301C\nDate/Time: Saturday\, February 26th at 2:35 PM \nSunday\, February 27\, 2022\nPoster presentation: Significant Reduction of Specific Allergen Levels in Baked Egg Foods\nPresenter: Stephanie Filep\nLocation: Convention Center\, North Building\, Lower Level\, Hall 4\, Poster 339\nDate/Time: Sunday\, February 27th from 9:45-10:45 AM \nMonday\, February 28\, 2022\nPoster presentation: Unique Epitope for a Natural Human IgE Monoclonal Antibody on Der p 2\nPresenter: Anna Pomés\, PhD FAAAAI\nLocation: Convention Center\, North Building\, Lower Level\, Hall 4\, Poster 659\nDate/Time: Monday\, February 28th from 9:45-10:45 AM \nPoster presentation: Evolution and functional significance of cat allergen\, Fel d 1\nPresenter: Nicole Brackett\, PhD\nLocation: Convention Center\, North Building\, Lower Level\, Hall 4. Poster 656\nDate/Time: Monday\, February 28th from 9:45-10:45 AM \n 
URL:https://inbio.com/event/inbio-attending-aaaai-annual-meeting-2022/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211208T110000
DTEND;TZID=America/New_York:20211208T120000
DTSTAMP:20260405T085426
CREATED:20221108T150332Z
LAST-MODIFIED:20221108T153451Z
UID:534-1638961200-1638964800@inbio.com
SUMMARY:CRISPR Cat Webinar
DESCRIPTION:Gene Editing of the Major Cat Allergen\, Fel d 1\nIndoor Biotechnologies is applying CRISPR gene editing to delete Fel d 1 from cat cells\, an approach to creating a hypoallergenic cat. Join Indoor Biotechnologies scientists to discuss details of the CRISPR Cat project on the holiday edition of our webinar series on Wednesday\, December 8th at 11am EST. \nIndoor Biotechnologies scientists are investigating the role of Fel d 1 across all cats\, both domesticated and wild. Fel d 1 is the cat allergen of choice as it accounts for 60-90% of anti-cat IgE. Significant research has been conducted at Indoor Biotechnologies to identify conserved regions of the Fel d 1 genes and to delete Fel d 1 from feline cells using CRISPR as an approach that could ultimately be used to generate Fel d 1-free cats.\nThe webinar will cover CRISPR Cat in detail\, providing the origins\, technical background\, data\, and future goals of the project. \nLearning Objectives:\n\nLearn more on the history of CRISPR Cat\, including how the gene for Fel d 1 was first isolated.\nLearn more about CRISPR Cat milestones to date\, including the development\, methods\, and results.\nUnderstand the importance of CRISPR Cat\, and how the project may have larger implications on the application of CRISPR technology in allergy.
URL:https://inbio.com/event/crispr-cat-webinar/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211027T110000
DTEND;TZID=America/New_York:20211027T120000
DTSTAMP:20260405T085426
CREATED:20221108T150031Z
LAST-MODIFIED:20221108T153413Z
UID:533-1635332400-1635336000@inbio.com
SUMMARY:SARS-CoV-2 Proteins and Simple T Cell Test Webinar
DESCRIPTION:SARS-CoV-2 Proteins and Simple T cell Test: Essential Tools for COVID-19 Research and Development\nIndoor Biotechnologies has a suite of SARS-CoV-2 proteins in various expression systems\, as well as a rapid whole blood T cell test in development. Join Indoor Biotechnologies scientists to discuss details of these products and technologies on our latest webinar on Wednesday\, October 27th at 11am EDT. \nIndoor Biotechnologies has used its proven expertise in structural biology\, protein expression and purification to manufacture a suite of recombinant SARS-CoV-2 proteins\, including a full-length spike protein. These proteins have been engineered\, optimized and expressed in both mammalian and bacterial expression systems. \nInBio® SARS-CoV-2 proteins are validated for purity by LC-MS/MS\, and their IgG reactivity tested using COVID-19 positive patients’ sera by ELISA. These proteins are manufactured under an ISO 9001:2015 certified Quality Management System. \nIndoor Biotechnologies has developed a rapid whole blood T cell test as part of an Innovate UK grant for assessment of vaccine or viral induced T cell response to SARS-CoV-2. Individuals exposed to SARS-CoV-2 may not produce long-lasting protective antibodies. T cell assays may be an important complement to COVID-19 diagnostic testing and vaccine development. \nInitial trials from InBio® show that the T cell test correlates with PCR and antibody responses and that the test can be used to monitor changes in T cell responses after vaccination. \nPreviously\, virus specific T cell tests have been difficult to standardize and require specific knowledge/equipment\, which presents a significant barrier for large scale\, effective testing. The InBio® simple T cell test aims to break these barriers and is being  optimized for easy implementation\, enabling high throughput testing of COVID-19 T cell immunity. \nThe webinar will cover these products in detail\, providing technical background\, data\, and applications. \nLearning Objectives:\n\nLearn more on the available suite of SARS-CoV-2 proteins\, including ELISA data comparing SARS-CoV-2 nucleocapsid RNA binding domain vs full-length spike proteins in determining vaccine efficiency.\nLearn more about the InBio® simple T cell test\, including the development\, milestones\, and future goals.\nUnderstand how Indoor Biotechnologies’ SARS-CoV-2 resources can aid in COVID-19 research\, diagnostics\, and vaccine efforts.
URL:https://inbio.com/event/sars-cov-2-proteins-and-simple-t-cell-test-webinar/
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR